ArticlePublished 29 Nov 2022
Drug Development and Validation of Elemental Impurities Content in Methotrexate Injection USP 250 mg/10 ml by Inductively Coupled Plasma Mass Spectroscopy (ICP-MS)
Abstract
Select any words in the title or abstract, or press this and choose a sentence.
Background and objectives: Validation of elemental Impurities Content in Methotrexate injection USP 250 mg/10 mL. Methods: This was achieved by using internal standard method with Inductively Coupled Plasma Mass Spectroscopy in KED mode with diluent concentration nitric acid and Hydrochloric Acid. Results: System meets the system suitability criteria as specified in USP method of analysis. % Recovery for each analyte was found within the specified limit 70.0–150.0 for 100% level. Conclusion: The system suitability and sample % recovery found within the range of 70% to 150% and this method is used for validation of Methotrexate Injection USP
Subjects
Pharmaceutical SciencesAsk about this article
Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.
Conferences in this field
Upcoming conferences in this field.
Follow
New articles from what you follow go into your email digest, once you agree to alert emails.
- JournalJournal of Drug and Alcohol Research
- SubjectPharmaceutical Sciences
- BylineArticles whose byline prints “Smruti Ranjan Mohanty”
- BylineArticles whose byline prints “Susanta Kumar Panda”